{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:00:39Z","timestamp":1778313639628,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271847"],"award-info":[{"award-number":["82271847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tongji Hospital Clinical Research Flagship Program","award":["No.2024TJCR008"],"award-info":[{"award-number":["No.2024TJCR008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10067-025-07456-2","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T15:07:29Z","timestamp":1747321649000},"page":"3033-3047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The clinical and immunological features of CMV infection in rheumatic patients: a nested case-control study"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4811-5440","authenticated-orcid":false,"given":"Junlai","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6887-658X","authenticated-orcid":false,"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4861-4864","authenticated-orcid":false,"given":"Bingxia","family":"Ming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6778-9745","authenticated-orcid":false,"given":"Shaozhe","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-1125","authenticated-orcid":false,"given":"Lingli","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"7456_CR1","doi-asserted-by":"publisher","first-page":"2786841","DOI":"10.1155\/2022\/2786841","volume":"2022","author":"WJ Wang","year":"2022","unstructured":"Wang WJ, Feng M, He F et al (2022) The viral load of human cytomegalovirus infection in children following hematopoietic stem cell transplant by chip digital PCR. Can J Infect Dis Med Microbiol 2022:2786841","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"5","key":"7456_CR2","doi-asserted-by":"publisher","first-page":"e0303995","DOI":"10.1371\/journal.pone.0303995","volume":"19","author":"T Tassaneeyasin","year":"2024","unstructured":"Tassaneeyasin T, Sungkanuparph S, Srichatrapimuk S et al (2024) Prevalence and risk factors of cytomegalovirus reactivation in critically Ill patients with COVID-19 pneumonia. PLoS ONE 19(5):e0303995","journal-title":"PLoS ONE"},{"issue":"9","key":"7456_CR3","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1007\/s00296-011-2131-4","volume":"32","author":"WP Tsai","year":"2012","unstructured":"Tsai WP, Chen MH, Lee MH et al (2012) Cytomegalovirus infection causes morbidity and mortality in patients with autoimmune diseases, particularly systemic lupus: in a Chinese population in Taiwan. Rheumatol Int 32(9):2901\u20132908","journal-title":"Rheumatol Int"},{"key":"7456_CR4","doi-asserted-by":"publisher","first-page":"1287456","DOI":"10.3389\/fimmu.2023.1287456","volume":"14","author":"D Yang","year":"2023","unstructured":"Yang D, Yao Y, Sun Y et al (2023) Refractory cytomegalovirus infections in Chinese patients receiving allogeneic hematopoietic cell transplantation: a review of the literature. Front Immunol 14:1287456","journal-title":"Front Immunol"},{"issue":"1","key":"7456_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11904-016-0297-9","volume":"13","author":"ML Freeman","year":"2016","unstructured":"Freeman ML, Lederman MM, Gianella S (2016) Partners in crime: the role of CMV in immune dysregulation and clinical outcome during HIV infection. Curr HIV\/AIDS Rep 13(1):10\u201319","journal-title":"Curr HIV\/AIDS Rep"},{"key":"7456_CR6","doi-asserted-by":"publisher","first-page":"1323923","DOI":"10.3389\/fimmu.2024.1323923","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhang L, Liu Y et al (2024) Clinical features and prognosis of systemic lupus erythematosus complicated by active cytomegalovirus infection: a retrospective cohort study. Front Immunol 15:1323923","journal-title":"Front Immunol"},{"issue":"8","key":"7456_CR7","doi-asserted-by":"publisher","first-page":"e0221793","DOI":"10.1371\/journal.pone.0221793","volume":"14","author":"J Cui","year":"2019","unstructured":"Cui J, Yan W, Xie H et al (2019) Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: a 10-year single hospital experience. PLoS ONE 14(8):e0221793","journal-title":"PLoS ONE"},{"issue":"11","key":"7456_CR8","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.jiac.2022.07.004","volume":"28","author":"H Ogata","year":"2022","unstructured":"Ogata H, Aoki N, Nagano K et al (2022) Factors associated with cytomegalovirus antigenemia in patients with rheumatic disease: a retrospective study. J Infect Chemother 28(11):1471\u20131477","journal-title":"J Infect Chemother"},{"issue":"1","key":"7456_CR9","doi-asserted-by":"publisher","first-page":"20926","DOI":"10.1038\/s41598-022-25451-4","volume":"12","author":"T Shimada","year":"2022","unstructured":"Shimada T, Higashida-Konishi M, Izumi K et al (2022) Risk factors associated with cytomegalovirus reactivation in patients receiving immunosuppressive therapy for rheumatic diseases: a retrospective study. Sci Rep 12(1):20926","journal-title":"Sci Rep"},{"issue":"1","key":"7456_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/14397595.2018.1551264","volume":"30","author":"S Kaneshita","year":"2020","unstructured":"Kaneshita S, Kida T, Yokota I et al (2020) Risk factors for cytomegalovirus disease with cytomegalovirus re-activation in patients with rheumatic disease. Mod Rheumatol 30(1):109\u2013115","journal-title":"Mod Rheumatol"},{"issue":"1","key":"7456_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s42358-019-0055-y","volume":"59","author":"H Choo","year":"2019","unstructured":"Choo H, Cher WQ, Kwan YH et al (2019) Risk factors for cytomegalovirus disease in systemic lupus erythematosus (SLE): a systematic review. Adv Rheumatol 59(1):12","journal-title":"Adv Rheumatol"},{"issue":"8","key":"7456_CR12","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1086\/339329","volume":"34","author":"P Ljungman","year":"2002","unstructured":"Ljungman P, Griffiths P, Paya C (2002) Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 34(8):1094\u20131097","journal-title":"Clin Infect Dis"},{"issue":"2","key":"7456_CR13","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288\u2013291","journal-title":"J Rheumatol"},{"issue":"Suppl 11","key":"7456_CR14","first-page":"S118","volume":"63","author":"LG Rider","year":"2011","unstructured":"Rider LG, Werth VP, Huber AM et al (2011) Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken) 63(Suppl 11):S118\u2013)S157","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"7456_CR15","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D et al (2009) Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68(12):1827\u20131832","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"7456_CR16","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1093\/cid\/ciac892","volume":"76","author":"M Fang","year":"2023","unstructured":"Fang M, Lin X, Wang C et al (2023) High cytomegalovirus viral load is associated with 182-day all-cause mortality in hospitalized people with human immunodeficiency virus. Clin Infect Dis 76(7):1266\u20131275","journal-title":"Clin Infect Dis"},{"issue":"11","key":"7456_CR17","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.tim.2020.04.003","volume":"28","author":"V Sandon\u00eds","year":"2020","unstructured":"Sandon\u00eds V, Garc\u00eda-R\u00edos E, McConnell MJ et al (2020) Role of neutralizing antibodies in CMV infection: implications for new therapeutic approaches. Trends Microbiol 28(11):900\u2013912","journal-title":"Trends Microbiol"},{"issue":"1","key":"7456_CR18","doi-asserted-by":"publisher","first-page":"9662","DOI":"10.1038\/s41598-020-66804-1","volume":"10","author":"AH Hsieh","year":"2020","unstructured":"Hsieh AH, Kuo CF, Chou IJ et al (2020) Human cytomegalovirus pp65 peptide-induced autoantibodies cross-reacts with TAF9 protein and induces lupus-like autoimmunity in BALB\/c mice. Sci Rep 10(1):9662","journal-title":"Sci Rep"},{"issue":"8","key":"7456_CR19","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/1346-8138.15409","volume":"47","author":"A Sekiguchi","year":"2020","unstructured":"Sekiguchi A, Inoue Y, Yamazaki S et al (2020) Demographic and clinical characteristics of cytomegalovirus reactivation in dermatomyositis. J Dermatol 47(8):876\u2013881","journal-title":"J Dermatol"},{"issue":"7","key":"7456_CR20","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00296-019-04324-6","volume":"39","author":"BJ Gardiner","year":"2019","unstructured":"Gardiner BJ, Haas EM, Bailey RC et al (2019) Reactivation of latent cytomegalovirus infection in patients with rheumatologic disease: a case-control study. Rheumatol Int 39(7):1229\u20131240","journal-title":"Rheumatol Int"},{"issue":"9","key":"7456_CR21","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/rheumatology\/ken231","volume":"47","author":"Y Takizawa","year":"2008","unstructured":"Takizawa Y, Inokuma S, Tanaka Y et al (2008) Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population. Rheumatology (Oxford) 47(9):1373\u20131378","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"7456_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/cid\/ciw668","volume":"64","author":"P Ljungman","year":"2017","unstructured":"Ljungman P, Boeckh M, Hirsch HH et al (2017) Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis 64(1):87\u201391","journal-title":"Clin Infect Dis"},{"issue":"9","key":"7456_CR23","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1016\/j.transproceed.2005.09.153","volume":"37","author":"E Sarmiento","year":"2005","unstructured":"Sarmiento E, Rodr\u00edguez-Molina J, Mu\u00f1oz P et al (2005) Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation. Transplant Proc 37(9):4046\u20134049","journal-title":"Transplant Proc"},{"issue":"1","key":"7456_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.intimp.2004.09.006","volume":"5","author":"E Sarmiento","year":"2005","unstructured":"Sarmiento E, Fern\u00e0ndez-Y\u00e1\u00f1ez J, Mu\u00f1oz P et al (2005) Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease. Int Immunopharmacol 5(1):97\u2013101","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"7456_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1684\/ejd.2011.1280","volume":"21","author":"Y Kanetaka","year":"2011","unstructured":"Kanetaka Y, Kano Y, Hirahara K et al (2011) Relationship between cytomegalovirus reactivation and dermatomyositis. Eur J Dermatol 21(2):248\u2013253","journal-title":"Eur J Dermatol"},{"issue":"Suppl 3","key":"7456_CR26","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/TP.0000000000001097","volume":"100","author":"U Schulz","year":"2016","unstructured":"Schulz U, Solidoro P, M\u00fcller V et al (2016) CMV immunoglobulins for the treatment of CMV infections in thoracic transplant recipients. Transplantation 100(Suppl 3):S5\u2013S10","journal-title":"Transplantation"},{"issue":"6","key":"7456_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41577-022-00716-1","volume":"22","author":"SJ Kent","year":"2022","unstructured":"Kent SJ, Khoury DS, Reynaldi A et al (2022) Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast. Nat Rev Immunol 22(6):387\u2013397","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"7456_CR28","doi-asserted-by":"publisher","first-page":"a030338","DOI":"10.1101\/cshperspect.a030338","volume":"10","author":"J Zhu","year":"2018","unstructured":"Zhu J (2018) T helper cell differentiation, heterogeneity, and plasticity. Cold Spring Harb Perspect Biol 10(10):a030338","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"7456_CR29","doi-asserted-by":"publisher","first-page":"1288234","DOI":"10.3389\/fimmu.2024.1288234","volume":"15","author":"R Hou","year":"2024","unstructured":"Hou R, Lei J, Xue D et al (2024) The association of an elevated Th\/Ts ratio and lupus anticoagulant with symptomatic osteonecrosis in systemic lupus erythematosus patients. Front Immunol 15:1288234","journal-title":"Front Immunol"},{"issue":"6","key":"7456_CR30","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00296-022-05196-z","volume":"43","author":"K Suga","year":"2023","unstructured":"Suga K, Nishiwaki A, Nakamura T et al (2023) Clinical significance of cytomegalovirus (CMV) pp65 antigenemia in the prediction of CMV infection during immunosuppressive therapy for rheumatic disease. Rheumatol Int 43(6):1093\u20131099","journal-title":"Rheumatol Int"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07456-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07456-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07456-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T07:46:20Z","timestamp":1751874380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07456-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["7456"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07456-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"16 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}